相关实验视频

Updated: Jun 13, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

特里戈内林类化合物有效地预防多克索鲁比诱导的肺损伤

Hamit Uslu¹, Gözde Atila Uslu¹, Betül Çiçek¹

¹Department of Physiology, Erzincan Binali Yıldırım University, Erzincan, Türkiye.

Archives of physiology and biochemistry

|September 17, 2024

概括

三素化物 (TRIG) 的预处理可以保护肺部免受多克索鲁比 (DOX) 化疗损伤. 通过阻断关键炎症通路,TRIG抑制了亡和炎症,提供了一个潜在的保护策略.

科学领域:

药理学药理学是指药理学的学科.
毒理学毒理学毒理学
细胞生物学细胞生物学

背景情况:

多克索鲁比 (DOX) 是一种广泛使用的化疗药物,已知有毒副作用.
DOX诱导损伤的关键机制包括氧化应激,炎症和亡.
肺部损伤是与DOX治疗相关的一大问题.

研究的目的:

调查三素化物 (TRIG) 在预防多克索鲁比诱导的肺损伤方面的疗效.
探索TRIG对NF-κB/MAPK炎症途径和细胞亡的影响.

主要方法:

这项研究涉及四组:对照组,TRIG,DOX和TRIG+DOX.
动物在7天内接受50mg/kg的TRIG,然后在第8天接受一次15mg/kg的DOX剂量.
评估了亡标志物和炎症指标.

主要成果:

多克索鲁比 (DOX) 治疗显著增加了亡标志物和肺组织中的炎症.
特里戈内林化物 (TRIG) 预处理部分抑制了DOX诱导的亡.
通过阻断MAPK/NF-κB通路并降低IL-6水平,从而保护肺细胞,TRIG降低了炎症.

结论:

特里戈内林化物 (TRIG) 显示出对多克索鲁比诱导的肺损伤的保护作用.
通过通过MAPK/NF-κB通路抑制亡和炎症,TRIG可以减轻肺损伤.
这项研究为进一步研究TRIG作为化学保护剂提供了基础.

关键词:

德克索鲁比辛是一种多克索鲁比辛.在 NF-κB/MAPKK 中.灭症 (apoptosis) 是一种死亡的过程.这是一种炎症炎症炎症炎症.这种类型的化物是trigonelline.

更多相关视频

An Improved Method for Rapid Intubation of the Trachea in Mice

An Improved Method for Rapid Intubation of the Trachea in Mice

Published on: February 22, 2016

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...